Maftivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).
Property | Value |
---|---|
dbo:abstract |
|
dbo:casNumber |
|
dbo:class | |
dbo:fdaUniiCode |
|
dbo:kegg |
|
dbo:wikiPageExternalLink | |
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink | |
dbp:atcPrefix |
|
dbp:c |
|
dbp:casNumber |
|
dbp:class | |
dbp:dailymedid |
|
dbp:h |
|
dbp:kegg |
|
dbp:mabType |
|
dbp:n |
|
dbp:o |
|
dbp:pregnancyUs |
|
dbp:pronounce |
|
dbp:s |
|
dbp:source |
|
dbp:target |
|
dbp:type |
|
dbp:unii |
|
dbp:wikiPageUsesTemplate | |
dcterms:subject | |
rdf:type | |
rdfs:comment |
|
rdfs:label |
|
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:isPrimaryTopicOf | |
is dbo:wikiPageWikiLink of | |
is foaf:primaryTopic of |